GLP-1 Evidence

Not medical advice. A record of published research and our assessments of it. The limits

Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period

Kindel TL, Wang AY, Wadhwa A, Schulman AR et al. · Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery · Dec 1, 2024
DOI 10.1016/j.soard.2024.08.033 · PubMed 39482213

Design
Guideline · Unknown outcome
Match to healthy normal-weight adults aged 55–75
Population unclearPractice guidance; applies to any user undergoing anaesthesia.
Could weight loss explain it?
Not applicable[Auto] Not a primary outcome study.
Study tier
Not ratedMultisociety consensus guidance on perioperative management (delayed gastric emptying and aspiration risk); no abstract in PubMed.
Assessment
Version 2 · curated · Sep 13, 2026

Study facts come from the paper. Population match, weight-loss explanation and study tier are our judgments, made against the reference group of healthy normal-weight adults aged 55–75.

Guidance from several surgical, anaesthesia and gastroenterology societies on managing GLP-1 users around procedures because of delayed stomach emptying and aspiration risk. Consult the full document for specifics.

01Findings

What the study reported

Drugs
Class unspecified
Primary outcome
Not extracted
Effect
Not extracted
95% confidence interval
Not extracted
Follow-up
Not stated
Adverse events
Not extracted
Limitations
Auto-classified from abstract only; effect estimates, adverse events and limitations not extracted. Requires manual review.

Who was studied

Study quality details

Study design
Guideline / practice guidance
Sample size
not extracted
Randomization
no
Blinding
not stated
Comparator
not stated
Follow up duration
not stated
Outcome type
unknown
Replication
not assessed (auto)
Consistency with other evidence
not assessed (auto)
Population applicability
UNKNOWN
Statistical precision
not extracted
Risk of bias
not assessed (auto)
Funding conflicts
unclear
Peer review status
yes
02Funding

Funding and conflicts

Funding
Professional societies
Industry funded
Unclear
Manufacturer
None identified
Sponsor role
not reported in abstract
Author conflicts
Not available in metadata.
Independent replication
unknown

Funding is shown on every study and never used to score it.

04Source

The source, as retrieved

Abstract

No abstract retrieved.

Where this record came from

SourceRetrievedIdentifier
pubmedSep 13, 202639482213
first ingestion